CGON
CG Oncology·NASDAQ
--
--(--)
--
--(--)
CGON fundamentals
CG Oncology (CGON) released its earnings on Nov 14, 2025: revenue was 1.67M (YoY +3774.42%), beat estimates; EPS was -0.57 (YoY -90.00%), missed estimates.
Revenue / YoY
1.67M
+3774.42%
EPS / YoY
-0.57
-90.00%
Report date
Nov 14, 2025
EPS
Actual | -0.28 | -0.46 | -0.45 | -0.54 | -0.57 |
Forecast | -0.356 | -0.3453 | -0.4036 | -0.4656 | -0.559 |
Surprise | +21.35% | -33.22% | -11.50% | -15.98% | -1.97% |
Revenue
Actual | 111.00K | 459.00K | 52.00K | 0 | 1.67M |
Forecast | 209.67K | 106.73K | 188.34K | 101.29K | 59.36K |
Surprise | -47.06% | +330.05% | -72.39% | -100.00% | +2706.41% |
Earnings Call
You can ask Aime
What were the key takeaways from CG Oncology’s earnings call?What factors drove the changes in CG Oncology's revenue and profit?What is CG Oncology's gross profit margin?What is the market's earnings forecast for CG Oncology next quarter?What were the key takeaways from CG Oncology's earnings call?What does CG Oncology do and what are its main business segments?What is CG Oncology's latest dividend and current dividend yield?Did CG Oncology beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
